CATHERINE MIRA: Open Payments
NPI 1659037406 · BELLAIRE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,155 in 38 payments from 9 companies in 2025. Trend: 2023 $1,407 · 2024 $5,347 · 2025 $1,155
Food & beverage: $955Consulting: $200
| Company | Payments | Amount |
|---|---|---|
| Avadel CNS Pharmaceuticals, LLC | 19 | $474 |
| SK Life Science, Inc. | 4 | $197 |
| Axsome Therapeutics, Inc. | 5 | $142 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| JAZZ PHARMACEUTICALS INC. | 4 | $108 |
| HARMONY BIOSCIENCES LLC | 2 | $59 |
| Optinose US, Inc. | 1 | $21 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $15 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
Products named: LUMRYZ, Sunosi, NUCALA, XYWAV, WAKIX, Xhance, NEFFY, HORIZANT.
Industry payments across TX — which companies pay providers there.
